November 10, 2025 · Form 4 insider transaction
O'Kane Kieran bought 75 shares of BIODESIX INC, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.
These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025 (the "Reverse Stock Split").; Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's Common Stock.; Includes 309 shares of the Issuer's Common Stock, as adjusted for the Reverse Stock Split, purchased under the Issuer's Employee Stock Purchase Plan on September 2, 2025.